BridgeBio Pharma, Inc. Weighted Average Shares Growth

Weighted Average Shares Growth of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Weighted Average Shares Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Weighted Average Shares Growth for the quarter ending September 30, 2022 was 0.87% (a -1840.0% decrease compared to previous quarter)
  • Year-over-year quarterly Weighted Average Shares Growth decreased by -96.11%
  • Annual Weighted Average Shares Growth for 2021 was 22.34% (a 82.07% increase from previous year)
  • Annual Weighted Average Shares Growth for 2020 was 12.27% (a -82.51% decrease from previous year)
  • Annual Weighted Average Shares Growth for 2019 was 70.15% (a -31.13% decrease from previous year)
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Weighted Average Shares Growth of BridgeBio Pharma, Inc.

Most recent Weighted Average Shares Growthof BBIO including historical data for past 10 years.

Interactive Chart of Weighted Average Shares Growth of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. Weighted Average Shares Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.87% -0.05% 5.23%
2021 22.34% 24.11% 25.42% 17.68% 22.34%
2020 12.27% 0.94% 25.96% 27.59% 12.27%
2019 72.43% -0.93% -20.61% -21.62% 70.15%
2018 -42.01% 101.86%
2017 89.83%

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology